View
353
Download
1
Tags:
Embed Size (px)
DESCRIPTION
FuBio Seminar 27.8.2013
Citation preview
CELLULOSE BEADS IN DRUG DELIVERY
Dr Ruzica Kolakovic
Åbo Akademi University
Department of Biosciences
Pharmaceutical Science Laboratory
Table of content
• Cellulose beads – production & properties
• Objectives of our work (Why CBs as drug carriers?)
• Our work with CBs so far
• Future plans/prospects
• Conclusions
Introduction Porous spherical cellulose particles with diameters in the micro- to
millimeterr scale.
Trygg et al., Chem. Rev.
Production
Yildir et al. submitted
Produced by coagulation of dissolved cellulose
Advantages of the production process
• Usage of environmental friendly solvents
• Possibility of tailoring in order to achieve beads of desirable properties
(size, porosity, charge, etc.)
• Possibility of scale up
Dissolving
Pulp
Dissolved
Cellulose
Pretreated
Pulp
Pretreatment in
Ethanol-Hydrochloric Acid
Mixing the pretreated pulp
with 7%NaOH and %12urea
Cellulose
Beads
Precipitation of dissolved cellulose
in 0.5 M HNO3 solution at 25° C
in 2M HNO3 solution at 25° C
in 2M HNO3 solution at 50° C
Properties
Why CBs in drug delivery?
• Non - toxicity
• Biocompatibility
• High porosity → large specific surface
area
• High mechanical strength
• Relatively low cost
• Irreversible agglomeration upon drying
(hornification)
Yildir et al. submitted
Good candidates as drug carriers
Aim of our work
Investigate possible application of CBs as drug carriers
• Drug loading capacity (entrapment efficacy)
• Drug release properties
• Processability (flow properties, tabletting abilities )
• Behavior of nonionic vs. anionic CBs
Our work with CBs so far
Drug loading (entrapment efficacy) studies have been performed with various
different compounds and several types of CBs (different charge, porosity, etc.)
Immersing method - simple two step method for drug loading
Drug loading efficacy Drug Type of CBs
Dug loading (%)
Theophylline
Non-ionic
T1 3.7
T2 4.2
T3 5.0
Lidocain hydrochloride
T1 23.2
T2 26.6
T3 27.3
Riboflavine sodium posphate
T1 12.7
T2 13.0
T3 14.3
Piroxicam T2 10.8
Griseofulvin T2 22.1
Ranitidine hydrochloride
Non-ionic 16.1
Anionic 20.1
Quinine sulphate Non-ionic 3.3
Anionic 11.8
Drug loading (entrapment efficacy) is
dependent on concentration of drug
loading solution, drug choice and CBs
properties
Morphology studies Quinine anionic
Ranitidin loaded non/ionic Ranitidin loaded anionic
Quinine non/ionic
Solid state characterization (FTIR)
CMC
Ranitidine hydrochloride
Interactions
Possible interactions between
anionic groups of CBs
(originating from CMC) and
positively charged drugs
Drug release properties
0
10
20
30
40
50
60
70
80
90
100
0 200 400 600 800
Cu
mu
lati
ve a
mo
un
t o
f d
rug
rele
ase
d
(%)
Time (min)
Quinine sulfate pure substance
Non-ionic beads
Anionic beads
Drug release dependent on type of CBs and choice of drug
Processability of CBs
Flow properties - angle of repose test
Good flow properties (similar or better
than common direct compression fillers)
Angle of repose of CBs,
~ 24-30 deg
Angle of repose of fast flo lactose ,
~ 35-40deg
Tabletting
CBs successfully compressed
into tablets
Application of CBs in future
Uniformity of drug loading
Possibility of dose adjustment
Personalized dosing
Because no two patients are alike
Every bead carries the same amount of drug
Dose is adjusted by choosing the needed number of beads
Future work and ideas
Oxidized CBs → contain larger portion of anionic groups (possibility
of reversible swelling and increase in loading capacity)
Hollow CBs → floating in aqueous medium
(possibility of gastro-retentive formulations)
Conclusions
CBs are promising drug carriers candidates
• Easy two step loading process
• Possibility of tailoring CBs properties and thus release properties
• Easy processing into dosage forms (capsules, tablets)
• Application in personalized dosing
Acknowledgements
M.Sc. Emrah Yildir Hanne Redant Laure De Boeck Dr. Natalja Genina Prof. Niklas Sandler
M. Sc. Jani Trygg Prof. Pedro Fardim
FuBio Cellulose
THANK YOU FOR YOUR ATTENTION !